Molecular Diagnostics Market to exceed US$ 20 Billion by 2024
For more Info: https://www.renub.com/molecular-diagnostics-market-nd.php Molecular diagnostics is termed as to the detection of genomic variants, with the aim to facilitate physicians in the detection, prognosis, diagnosis, sub-classification and further monitoring response to the given therapy. Molecular diagnostics is the outcome of productive relationships between genomics knowledge, laboratory medicine and the use of improved technology in the field of molecular genetics. All these factors help in the better recognition and fine categorization of the genetic basis of inherited diseases which in turn, is essential for the accurate specification of disease diagnosis. Global Molecular Diagnostics Market is projected to exceed US$ 20 Billion by the year 2024. Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS) Over the last few decades, several molecular assays have been developed using a variety of technologies. Molecular diagnostics by using Polymerase Chain Reaction (PCR) is one of the leading molecular diagnostics technologies, which is being used for the rapid diagnosis of various diseases. For instance: diagnosis of pulmonary tuberculosis using Polymerase Chain Reaction (PCR) is demonstrating a high yield even in patients with sputum smear-negative pulmonary tuberculosis and is now being endorsed for routine use by WHO. High-end molecular diagnostic techniques such as next-generation sequencing (NGS) offer valuable insights into the mechanisms of disease while genomic biomarkers provide physician not only to evaluate the disease predilection but also to implement accurate diagnostic techniques and to individualize medicinal modalities.
★
★
★
★
★
150 views • 13 slides
